Literature DB >> 24357167

[Nationwide statements from regional data: methods of the Center for Cancer Registry Data].

K Kraywinkel1, B Barnes, S Dahm, J Haberland, A Nennecke, R Stabenow.   

Abstract

Despite having achieved nationwide registry coverage in addition to substantial improvements in data on the epidemiology of cancer in Germany, the Centre for Cancer Registry Data continues to estimate national statistics on incidence, survival, and prevalence instead of calculating these directly from available data. The methods used for evaluations are based initially on estimates of registration completeness or, for survival analyses, an assessment of the quality of follow-up data. The completeness of incident case registration is estimated on the basis of the mortality/incidence procedure, which assumes a largely constant relationship between the mortality and incidence of a cancer type among people of the same age and sex across federal states. Inclusion criteria for consideration of registry data in national survival analyses are less than 15% of death certificate only (DCO) cases and plausible survival for patients with pancreatic cancer or metastatic lung cancer. Of the 477,300 incident cancer cases estimated for 2010, 429,900 were reported by the cancer registries (90%), and ten federal states contributed data to national survival estimates.

Entities:  

Mesh:

Year:  2014        PMID: 24357167     DOI: 10.1007/s00103-013-1878-z

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  3 in total

1.  Cancers Potentially Preventable through Excess Weight Reduction in Germany in 2010.

Authors:  Antje Wienecke; Hannelore Neuhauser; Klaus Kraywinkel; Benjamin Barnes
Journal:  Obes Facts       Date:  2018-10-17       Impact factor: 3.942

2.  Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries.

Authors:  Ljupcho Efremov; Semaw Ferede Abera; Ahmed Bedir; Dirk Vordermark; Daniel Medenwald
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-20       Impact factor: 4.553

Review 3.  State-of-the-art imaging for diagnosis of metastatic bone disease.

Authors:  Amanda Isaac; Danoob Dalili; Daniel Dalili; Marc-André Weber
Journal:  Radiologe       Date:  2020-11       Impact factor: 0.635

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.